Cargando…
Pharmacokinetics and metabolism of ifosfamide in relation to DNA damage assessed by the COMET assay in children with cancer
The degree of damage to DNA following ifosfamide (IFO) treatment may be linked to the therapeutic efficacy. The pharmacokinetics and metabolism of IFO were studied in 19 paediatric patients, mostly with rhabdomyosarcoma or Ewings sarcoma. Ifosfamide was dosed either as a continuous infusion or as fr...
Autores principales: | Willits, I, Price, L, Parry, A, Tilby, M J, Ford, D, Cholerton, S, Pearson, A D J, Boddy, A V |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362048/ https://www.ncbi.nlm.nih.gov/pubmed/15827549 http://dx.doi.org/10.1038/sj.bjc.6602554 |
Ejemplares similares
-
Platinum-DNA adduct formation in leucocytes of children in relation to pharmacokinetics after cisplatin and carboplatin therapy.
por: Peng, B., et al.
Publicado: (1997) -
Cell survival after DNA damage in the comet assay
por: Bankoglu, Ezgi Eyluel, et al.
Publicado: (2021) -
B-Comet Assay (Comet Assay on Buccal Cells) for the Evaluation of Primary DNA Damage in Human Biomonitoring Studies
por: Russo, Carla, et al.
Publicado: (2020) -
An ECVAG† trial on assessment of oxidative damage to DNA measured by the comet assay
por: Johansson, Clara, et al.
Publicado: (2010) -
Using the HepaCometChip Assay for Broad‐Spectrum DNA Damage Analysis
por: Owiti, Norah A., et al.
Publicado: (2022)